基于MR弹性成像预测持续病毒学应答的慢性乙型肝炎患者肝细胞癌发生
本研究纳入345例接受2D/3D MR弹性成像的慢性乙型肝炎患者,随机分为训练组243例和验证组102例,基于多变量Cox模型构建MRE风险评分预测肝细胞癌发生。2D/3D MRE风险评分在训练组和验证组的C-index均优于CAMD、PAGE-B和mPAGE-B评分(均p<0.05),3年和5年阴性预测值分别达97.8-100.0%和94.6-100.0%。结论认为2D和3D MRE风险评分可能成为预测CHB患者HCC发生的工具。
要点
- 2D/3D MRE风险评分在训练组和验证组C-index均高于CAMD、PAGE-B和mPAGE-B评分(均p<0.05)。
- 2D/3D MRE风险评分在3年和5年的阴性预测值分别达97.8-100.0%和94.6-100.0%。
- 2D和3D MRE所测硬度值是HCC发生的独立预测因子。
核心结论
- 2D和3D MRE风险评分可能作为预测CHB患者HCC发生的工具,且预测性能优于现有临床评分。
研究设计与样本
- 研究纳入2015年7月至2018年12月间接受2D/3D MRE的345例CHB患者,随机分为训练组243例和验证组102例,基于多变量Cox模型构建MRE风险评分并与既往临床评分比较,采用C-index和时间依赖ROC评估预测性能。
诊断标准与关键数值
- 2D MRE风险评分训练组C-index为0.859,验证组为0.878;3D MRE风险评分训练组C-index为0.872,验证组为0.887。
- CAMD评分训练组C-index为0.762,验证组为0.815;PAGE-B评分训练组为0.754,验证组为0.709;mPAGE-B评分训练组为0.818,验证组为0.810。
- 2D MRE风险评分两个最佳截断值分别为43.2和69.2,3D MRE风险评分两个最佳截断值分别为56.5和71.6。
- 2D和3D MRE风险评分在训练组和验证组的3年阴性预测值为97.8-100.0%,5年阴性预测值为94.6-100.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The goal of this study was to develop a risk score based on MR elastography (MRE) to predict hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB).
MATERIALS AND METHODS: A total of 345 patients with CHB who underwent 2D/3D MRE between July 2015 and December 2018 were enrolled and then randomly assigned to training (n = 243) and validation (n = 102) cohorts. An MRE-based HCC risk score was developed for the prediction of HCC development based on a multivariable Cox model and compared with previous clinical scores. The predictive performance was evaluated using the C-index and time-dependent ROC.
RESULTS: The 2D/3D MRE-based risk scores incorporating age, platelet count, albumin, and liver stiffness provided better predictive performance in HCC development than three existing clinical risk scores [CAMD (cirrhosis, age, male sex, and diabetes mellitus), PAGE-B (platelet age gender-B), and mPAGE-B (modified platelets, age, gender-hepatitis B)] in the training (C-index: 0.859 and 0.872, respectively, vs 0.762, 0.754 and 0.818, all p value < 0.05) and validation cohorts (C-index: 0.878 and 0.887, respectively, vs 0.815, 0.709 and 0.810, all p value < 0.05). The 2D and 3D MRE-based risk scores provided high negative predictive values in the training and validation cohorts at 3 years (97.8-100.0%) and 5 years (94.6-100.0%) with the two optimal cut-off values of 43.2 and 69.2, respectively, and 56.5 and 71.6, respectively.
CONCLUSIONS: Both 2D and 3D MRE-based risk scores may serve as a valuable tool for predication of HCC development for CHB patients and provided superior predictive performance compared to existing clinical scores.
KEY POINTS: Question Can MRE be a useful component of a risk score to predict HCC development in CHB patients with sustained virological response? Findings 2D/3D MRE-based stiffness values were independent predictors for HCC development, and the 2D/3D MRE-based risk scores demonstrated better performance than three existing clinical risk scores. Clinical relevance The 2D/3D MRE-based risk scores provide high negative predictive values for HCC development, which may become a noninvasive tool for clinicians to stratify CHB patients for HCC surveillance and to improve early HCC detection and reduce mortality.
引用
- Chen H, Zhu J, Zhou J, et al. MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response. Eur Radiol. 2025. PMID: 40506638. doi:10.1007/s00330-025-11726-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。